Efficacy of a Recombinant Genotype VII Vaccine against Challenge with Velogenic Newcastle Disease Virus

Journal Title: Journal of Vaccines and Immunology - Year 2016, Vol 2, Issue 1

Abstract

Background: Newcastle disease virus (NDV) genotype VII has become the dominant genotype in China. However, NDV genotype II was used to make current commercial NDV vaccines. The mismatch of genotypes between circulating and vaccine strains of viruses may compromise the efficacy of vaccines. Methods: In this study, a current circulating NDV was attenuated by mutations of multiple basic amino acid motif of fusion cleavage site 112RRQKGF117 based on reverse genetic techniques. The recombinant virus was prepared as an inactivated vaccine to test its efficacy and compared with a commercial LaSota NDV vaccine on SPF chickens. Results: All vaccinated chickens survived by the end of the study. By contrast, the unvaccinated chickens were all dead before 5 days post-challenge (DPC). Compared to commercial LaSota vaccine, the experimental inactivated vaccine elicited earlier and higher titer of HI antibodies and had reduced titer and duration of virus shedding after challenge. Conclusion: The experimental inactivated NDV vaccine may work as a promising vaccine candidate to control the disease.

Authors and Affiliations

Cheng Yi, Sheng Dongbei, Li Xiangdong, Hong Sumei, Guo Lixia, Zhao Shasha, Yuan Yue, Xue Jingjing, Tian Hui, Ren Yipin, Liu Wujie

Keywords

Related Articles

Pathogenicity of Duck-Originated H9N2 Influenza Viruses on Chickens

Background: The spreading of H9N2 avian influenza viruses in poultry in Eurasia and Africa accompanied with the great economic losses to poultry industry in past decades has attracted the great attention of whole world....

Safety of the Novel Vector Vaccine Against Brucella Abortus Based on Recombinant Influenza Viruses Expressing Brucella L7/L12 and OMP16 Proteins, in Cattle

This paper presents the results of a study of the safety of new vector vaccine against B. abortus based on recombinant influenza A subtype H5N1 or H1N1 (viral constructs vaccine formulation) viruses expressing Brucella r...

Construction of Indonesian-Strain Avian Flu Virus Seed Vaccine Using Low Pathogenic Hemagglutinin Gene and Neuraminidase Pr8 Gene through Reverse Genetics

Avian Influenza H5N1 has been spreading in Indonesia since 2003. The Avian influenza virus H5N1 actually infects various animals, including birds, mammalian and others. Since 2005, avian influenza virus has infected huma...

Immunogenicity of Hydrolysate Formulas in Children (Part 1). Review of 202 Reactions

Cow's milk (CM) protein hydrolyzed formulas (HFs) appeared in the 40's with the aim of decreasing or eliminating the allergenicity of CM proteins, and in addition of reducing the risk of sensitization. In recent years th...

Lethal Food-Induced Anaphylaxis in Children

Despite careful contributions, food allergic children have a significant risk of anaphylactic episodes. Especially at risk are children not accompanied by parents or caregivers in public places, or restaurants, or not pr...

Download PDF file
  • EP ID EP553750
  • DOI 10.17352/jvi.000016
  • Views 94
  • Downloads 0

How To Cite

Cheng Yi, Sheng Dongbei, Li Xiangdong, Hong Sumei, Guo Lixia, Zhao Shasha, Yuan Yue, Xue Jingjing, Tian Hui, Ren Yipin, Liu Wujie (2016). Efficacy of a Recombinant Genotype VII Vaccine against Challenge with Velogenic Newcastle Disease Virus. Journal of Vaccines and Immunology, 2(1), 19-22. https://www.europub.co.uk/articles/-A-553750